Brick & Kyle Associates’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-32,631
| Closed | -$3.03M | – | 62 |
|
2024
Q2 | $3.03M | Sell |
32,631
-240
| -0.7% | -$22.2K | 1.25% | 31 |
|
2024
Q1 | $2.99M | Sell |
32,871
-425
| -1% | -$38.7K | 1.33% | 31 |
|
2023
Q4 | $2.97M | Sell |
33,296
-237
| -0.7% | -$21.2K | 1.48% | 31 |
|
2023
Q3 | $2.45M | Sell |
33,533
-200
| -0.6% | -$14.6K | 1.3% | 32 |
|
2023
Q2 | $2.8M | Sell |
33,733
-280
| -0.8% | -$23.2K | 1.5% | 27 |
|
2023
Q1 | $2.59M | Buy |
34,013
+618
| +2% | +$47.1K | 1.48% | 29 |
|
2022
Q4 | $2.77M | Buy |
33,395
+115
| +0.3% | +$9.55K | 1.61% | 29 |
|
2022
Q3 | $2.66M | Buy |
33,280
+115
| +0.3% | +$9.19K | 1.61% | 29 |
|
2022
Q2 | $2.45M | Buy |
33,165
+90
| +0.3% | +$6.64K | 1.37% | 34 |
|
2022
Q1 | $2.97M | Sell |
33,075
-29,763
| -47% | -$2.68M | 1.44% | 31 |
|
2021
Q4 | $7.04M | Buy |
62,838
+31,419
| +100% | +$3.52M | 1.64% | 27 |
|
2021
Q3 | $3.98M | Buy |
31,419
+62
| +0.2% | +$7.86K | 2.02% | 20 |
|
2021
Q2 | $4.29M | Sell |
31,357
-188
| -0.6% | -$25.7K | 2.24% | 20 |
|
2021
Q1 | $4.34M | Sell |
31,545
-149
| -0.5% | -$20.5K | 2.4% | 17 |
|
2020
Q4 | $4.47M | Sell |
31,694
-415
| -1% | -$58.6K | 2.79% | 12 |
|
2020
Q3 | $3.58M | Buy |
32,109
+152
| +0.5% | +$16.9K | 2.47% | 16 |
|
2020
Q2 | $3.55M | Buy |
31,957
+415
| +1% | +$46K | 2.64% | 14 |
|
2020
Q1 | $2.44M | Buy |
+31,542
| New | +$2.44M | 2.29% | 20 |
|
2019
Q4 | – | Sell |
-8,748
| Closed | -$722K | – | 71 |
|
2019
Q3 | $722K | Sell |
8,748
-675
| -7% | -$55.7K | 0.6% | 39 |
|
2019
Q2 | $813K | Buy |
+9,423
| New | +$813K | 0.77% | 34 |
|
2019
Q1 | – | Sell |
-9,548
| Closed | -$685K | – | 92 |
|
2018
Q4 | $685K | Buy |
+9,548
| New | +$685K | 0.65% | 45 |
|
2018
Q2 | $918K | Buy |
9,648
+75
| +0.8% | +$7.14K | 0.72% | 43 |
|
2018
Q1 | $840K | Sell |
9,573
-100
| -1% | -$8.78K | 0.68% | 45 |
|
2017
Q4 | $821K | Buy |
9,673
+575
| +6% | +$48.8K | 0.67% | 46 |
|
2017
Q3 | $788K | Buy |
9,098
+500
| +6% | +$43.3K | 0.64% | 49 |
|
2017
Q2 | $664K | Sell |
8,598
-600
| -7% | -$46.3K | 0.57% | 51 |
|
2017
Q1 | $638K | Hold |
9,198
| – | – | 0.49% | 53 |
|
2016
Q4 | $544K | Buy |
9,198
+100
| +1% | +$5.91K | 0.44% | 55 |
|
2016
Q3 | $603K | Hold |
9,098
| – | – | 0.48% | 52 |
|
2016
Q2 | $492K | Buy |
9,098
+450
| +5% | +$24.3K | 0.4% | 58 |
|
2016
Q1 | $447K | Buy |
8,648
+150
| +2% | +$7.75K | 0.39% | 58 |
|
2015
Q4 | $597K | Hold |
8,498
| – | – | 0.53% | 50 |
|
2015
Q3 | $529K | Sell |
8,498
-2,890
| -25% | -$180K | 0.5% | 51 |
|
2015
Q2 | $958K | Sell |
11,388
-75
| -0.7% | -$6.31K | 0.8% | 40 |
|
2015
Q1 | $862K | Buy |
11,463
+2,118
| +23% | +$159K | 0.74% | 40 |
|
2014
Q4 | $581K | Buy |
+9,345
| New | +$581K | 0.5% | 50 |
|